Leukemia, Prolymphocytic, B-Cell - 15 Studies Found Recruiting : Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia : B-Cell Prolymphocytic Leukemia Hypodiploidy Procedure: Allogeneic Bone Marrow Transplantation Not yet recruiting : Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma : Anemia B-Cell Prolymphocytic Leukemia Drug: Entospletinib Given PO Withdrawn : Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML : Lymphoproliferative Malignancies Acute Myeloid Leukemia : 2014-08-28 : Drug: ZEN003365 Recruiting : Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies : B-cell Non-Hodgkins Lymphoma Chronic Lymphocytic Leukemia : 2016-09-14 : Biological: XmAb13676 Biological Active, not recruiting : Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies : Leukemia : 2010-03-25 : Drug: Nelarabine Starting dose 200 mg/m2 for 5 day continuous infusion administered via a central cathet <<< Previous